Chemotherapy is an effective first line treatment for early stage gastric mucosa-associated lymphoid tissue lymphoma Fulltext Access 5 Pages 2006
High-resolution magnetic resonance cholangiography (MRC) with adaptive averaging: diagnostic performance evaluation Fulltext Access 5 Pages 2006
Antibiotics plus granulocyte colony-stimulating factor reduces febrile neutropenia in the first cycle of chemotherapy in people with small-cell lung cancer Fulltext Access 5 Pages 2006
Adding raltitrexed to cisplatin improves overall survival in people with malignant pleural mesothelioma Fulltext Access 5 Pages 2006
What kind of evidence do patients and practitioners need: Evidence profiles based on 5 key evidence-based principles to summarize data on benefits and harms Fulltext Access 5 Pages 2006
Every 3 weeks dosing with darbepoetin alfa: A new paradigm in anaemia management Fulltext Access 5 Pages 2006
European guidelines for the management of chemotherapy-induced anaemia and health economic aspects of treatment Fulltext Access 5 Pages 2006
Trastuzumab after primary treatment for early stage HER2-positive breast cancer reduces recurrence Fulltext Access 5 Pages 2006
Diagnostic accuracy of CT-guided percutaneous cutting needle biopsy for thymic tumours Fulltext Access 5 Pages 2006
Hormonal therapy for male breast cancer: A different approach for a different disease Fulltext Access 5 Pages 2006
Ondansetron, prochlorperazine, and dexamethasone have similar effects on prevention of delayed chemotherapy-induced nausea and vomiting Fulltext Access 5 Pages 2006
Adding a single high-dose chemotherapy cycle to three cycles of standard salvage chemotherapy for relapsed germ-cell tumours does not improve clinical outcomes Fulltext Access 5 Pages 2006
Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: Meta-analysis of randomized trials Fulltext Access 5 Pages 2006
Quality assurance methods for the first Radiation Therapy Oncology Group permanent prostate implant protocol Fulltext Access 5 Pages 2006
Real-time computed tomography dosimetry during ultrasound-guided brachytherapy for prostate cancer Fulltext Access 5 Pages 2006
Quality assurance of treatment plans for interstitial and intracavitary high-dose-rate brachytherapy Fulltext Access 5 Pages 2006
A simple technique for determining accurate urethral dosimetry after seed brachytherapy for prostate cancer Fulltext Access 5 Pages 2006
Relationship of the International Prostate Symptom score with urinary flow studies, and catheterization rates following 125I prostate brachytherapy Fulltext Access 5 Pages 2006
Comparative study of dosimetry between high-dose-rate and permanent prostate implant brachytherapies in patients with prostate adenocarcinoma Fulltext Access 5 Pages 2006
A descriptive analysis of postimplant dosimetric parameters from Radiation Therapy Oncology Group P0019 Fulltext Access 5 Pages 2006
Active surveillance with selective delayed intervention for favorable risk prostate cancer Fulltext Access 5 Pages 2006
Primary Radical Radiotherapy for Squamous Cell Carcinoma of the Middle Ear and External Auditory Canal - an Historical Series Fulltext Access 5 Pages 2006
Plasminogen Activator Inhibitor-1 Promoter Polymorphism is Not Associated With the Aggressiveness of Disease in Prostate Cancer Fulltext Access 5 Pages 2006
Carboplatin and Hypofractionated Accelerated Radiotherapy: A Dose Escalation Study of an Outpatient Chemoradiation Schedule for Squamous Cell Carcinoma of the Head and Neck Fulltext Access 5 Pages 2006
Metastatic Struma Ovarii: Late Presentation, Unusual Features and Multiple Radioactive Iodine Treatments Fulltext Access 5 Pages 2006
A Pilot Study of Brain Tumour Growth Between Radiotherapy Planning and Delivery Fulltext Access 5 Pages 2006
Diagnosis of Bone Metastasis in Men with Prostate Cancer by Measurement of Serum ICTP in Combination with Alkali Phosphatase and Prostate-specific Antigen Fulltext Access 5 Pages 2006
Smoking Compromises Cause-specific Survival in Patients with Operable Colorectal Cancer Fulltext Access 5 Pages 2006
The Combination of Raltitrexed (Tomudex) and Mitomycin-C in the Treatment of Advanced Colorectal Cancer - A Phase II Study Fulltext Access 5 Pages 2006
Treatment of Benign Diseases with Megavoltage X-ray Beams: Is there a Risk for Gonadal Damage? Fulltext Access 5 Pages 2006
Characterization and Localization of Prostatic Alpha1 Adrenoceptors Using Radioligand Receptor Binding on Slide-Mounted Tissue Section Fulltext Access 5 Pages 2006
Evaluation of the surface radiation dose and dose gradient in early stage breast cancer using high-dose-rate brachytherapy MammoSite⢠applicator Fulltext Access 5 Pages 2006
Health related quality of life outcomes after radical prostatectomy: Attention to study design and the patient-based importance of single-surgeon studies Fulltext Access 5 Pages 2006
Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon α-2B for reducing recurrence of superficial bladder cancer Fulltext Access 5 Pages 2006
Small-cell neuroendocrine carcinoma as a variant form of prostate cancer recurrence: A case report and short literature review Fulltext Access 5 Pages 2006
Risk of renal insufficiency in African-Americans after radical nephrectomy for kidney cancer Fulltext Access 5 Pages 2006
Phase II study of capecitabine single-agent therapy in patients with metastatic renal cell carcinoma Fulltext Access 5 Pages 2006
Radiological findings of screen-detected cancers in a multi-centre randomized, controlled trial of mammographic screening in women from age 40 to 48 years Fulltext Access 5 Pages 2006
Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer Fulltext Access 5 Pages 2006
Incidence of ovarian cancer of grand multiparous women—A population-based study in Finland Fulltext Access 5 Pages 2006
Characterization of neutropenic fever in patients receiving first-line adjuvant chemotherapy for epithelial ovarian cancer Fulltext Access 5 Pages 2006
The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients Fulltext Access 5 Pages 2006
Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer Fulltext Access 5 Pages 2006
Final analysis of RTOG 9708: Adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer Fulltext Access 5 Pages 2006
Chemotherapy may be more effective in highly proliferative ovarian carcinomas—A translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol) Fulltext Access 5 Pages 2006
Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening Fulltext Access 5 Pages 2006
Two for good measure: Six versus eight cycles of carboplatin and paclitaxel as adjuvant treatment for epithelial ovarian cancer Fulltext Access 5 Pages 2006
The safety and efficacy of the weekly dosing of irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer Fulltext Access 5 Pages 2006
Atypical presentations of carboplatin hypersensitivity reactions: Characterization and management in patients with gynecologic malignancies Fulltext Access 5 Pages 2006
Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer Fulltext Access 5 Pages 2006
Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO2 laser vaporization, photodynamic therapy, excision and vulvectomy Fulltext Access 5 Pages 2006
F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy Fulltext Access 5 Pages 2006
Comparison of secondary and primary ovarian malignancies reveals differences in their pre- and perioperative characteristics Fulltext Access 5 Pages 2006
Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China Fulltext Access 5 Pages 2006
Palliative radiotherapy for recurrent granulosa cell tumor of the ovary: A report of 3 cases with radiological evidence of response Fulltext Access 5 Pages 2006
Aggressive multimodality treatment in transitional cell carcinoma of the parafallopian tube: Report of 2 cases and review of the literature Fulltext Access 5 Pages 2006
Langerhans' cells and smoking in intraepithelial neoplasia of the cervix Fulltext Access 5 Pages 2006
MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion Fulltext Access 5 Pages 2006
Low-dose warfarin does not decrease the rate of thrombosis in patients with cervix and vulvo-vaginal cancer treated with chemotherapy, radiation, and erythropoeitin Fulltext Access 5 Pages 2006
Individual fraction optimization vs. first fraction optimization for multichannel applicator vaginal cuff high-dose-rate brachytherapy Fulltext Access 5 Pages 2006
Prolonged stabilization of platinum-resistant ovarian cancer in a single patient consuming a fermented soy therapy Fulltext Access 5 Pages 2006
A phase I trial of gemcitabine and topotecan in previously treated ovarian or peritoneal cancer: A Gynecologic Oncology Group study Fulltext Access 5 Pages 2006
The role of hybrid PET/CT in the evaluation of patients with cervical cancer Fulltext Access 5 Pages 2006
Neoadjuvant chemotherapy in vulvar cancer: Avoiding primary exenteration Fulltext Access 5 Pages 2006
Ovarian cancer surgical resectability: Relative impact of disease, patient status, and surgeon Fulltext Access 5 Pages 2006
Comparison of uterine malignancies that develop during and following tamoxifen therapy Fulltext Access 5 Pages 2006
Histopathologic behavior of endometrial hyperplasia during tamoxifen therapy for breast cancer Fulltext Access 5 Pages 2006
A case–control study of methylenetetrahydrofolate reductase polymorphisms in cervical carcinogenesis Fulltext Access 5 Pages 2006
Molecular profiling of endometrial cancers from African–American and Caucasian women Fulltext Access 5 Pages 2006
Efficacy and toxicity of the novel chemotherapeutic agent KW-2170 in recurrent epithelial ovarian cancer Fulltext Access 5 Pages 2006
Prospective evaluations of continuous weekly paclitaxel regimen in recurrent platinum-resistant epithelial ovarian cancer Fulltext Access 5 Pages 2006
Consistent absence of BRAF mutations in cervical and endometrial cancer despite KRAS mutation status Fulltext Access 5 Pages 2006
Value of preoperative serum CA125 in early-stage adenocarcinoma of the uterine cervix without pelvic lymph node metastasis Fulltext Access 5 Pages 2006
A phase II evaluation of tirapazamine plus cisplatin in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study Fulltext Access 5 Pages 2006
Prevalence and prognostic significance of COX-2 expression in stage IB cervical cancer Fulltext Access 5 Pages 2006
A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the prognosis of patients with ovarian cancer Fulltext Access 5 Pages 2006
Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium Fulltext Access 5 Pages 2006
Squamous cell carcinoma with sarcomatoid features of the vulva: A case report and review of literature Fulltext Access 5 Pages 2006
Aggressive carcinosarcoma of the uterine cervix associated with high levels of granulocyte colony stimulating factor: Case report and laboratory correlates Fulltext Access 5 Pages 2006